Device Market for Ischemic Stroke Gains Momentum

article image

In 2015, five major clinical trials were published demonstrating the benefits of endovascular mechanical thrombectomy devices for the treatment of acute ischemic stroke, ushering in a new era in stroke treatment. Now companies are working to expand approved indications and build appropriate systems of stroke care to ensure that their devices can be used to treat as many stroke patients as possible.

Over the past 25 years, the market for stroke devices has been based almost entirely on the prevention of hemorrhagic stroke, or the treatment of brain aneurysms before they rupture and cause bleeding in the brain.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: